<DOC>
	<DOCNO>NCT02256787</DOCNO>
	<brief_summary>The objective current study investigate safety , tolerability , pharmacokinetics BILB 1941 ZW follow administration single rise dos 5 mg 300 mg . In addition bioavailability 60 mg dose give fasted high-fat breakfast investigate</brief_summary>
	<brief_title>Safety , Tolerance , Pharmacokinetics Single Rising Oral Doses BILB 1941 ZW Solution Healthy Male Subjects , Followed With Bioavailability Comparison BILB 1941 ZW Tablet Solution Formulation Administered With Without Food</brief_title>
	<detailed_description />
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<criteria>1 . Healthy male accord follow criterion base upon complete medical history , include physical examination , vital sign ( BP , PR ) , 12lead ECG , clinical laboratory test : 1.1 No find deviate normal clinical relevance 1.2 No evidence clinically relevant concomitant disease 2 . Age ≥18 Age ≤50 year , BMI ≥18.5 BMI ≤29.9 kg/m2 ( Body Mass Index ) 3 . Signed date write informed consent prior admission study accordance Good Clinical Practice ( GCP ) local legislation Any finding medical examination ( include blood pressure , pulse rate ECG ) deviate normal clinical relevance History current gastrointestinal , hepatic , renal , respiratory , cardiovascular , metabolic , immunologic , hormonal disorder , include clinical history viral hepatitis , serological evidence active Hepatitis B Hepatitis C infection History orthostatic hypotension , faint spell blackouts Diseases central nervous system ( epilepsy ) psychiatric disorder neurological disorder Chronic relevant acute infection History allergy/hypersensitivity ( include drug allergy ) deem relevant trial judge investigator Intake drug long halflife ( &gt; 24 hour ) within 1 month prior administration Use drug might influence result trial within 10 day prior administration trial Participation another trial investigational drug within 1 month prior administration trial Smoker ( &gt; 10 cigarette 3 cigar 3 pipes/day ) inability refrain smoke trial day Alcohol abuse ( &gt; 60 g/day ) Drug abuse Blood donation 100 mL within 1 month prior administration trial Excessive physical activity within 5 day prior administration trial Any laboratory value outside clinically accept reference range clinical relevance History familial bleeding disorder</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>October 2014</verification_date>
</DOC>